Trials / Recruiting
RecruitingNCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis (LN): the OBSErve-LN Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest. This study aims to provide the first long-term (up to 5 years) assessment of renal function preservation in belimumab treated participants.
Detailed description
This is a Phase 4 study and will involve both prospective and retrospective data collection from participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None (Observational study) | Not Applicable since Observational Study |
Timeline
- Start date
- 2024-10-04
- Primary completion
- 2029-03-29
- Completion
- 2029-03-29
- First posted
- 2024-07-30
- Last updated
- 2026-03-27
Locations
5 sites across 2 countries: United States, Japan
Source: ClinicalTrials.gov record NCT06527872. Inclusion in this directory is not an endorsement.